In this post, we will be taking a closer look at some of the most popular pulmonology-related articles recently published across medical journals.

Remission in asthma

  • Current Opinion in Pulmonary Medicine
  • May 2024
  • The purpose of this review is to examine the current understanding of remission in asthma. Moving forward, there is a need for a universally accepted, evidence-based, and user-friendly definition of remission that can be applied in routine clinical settings. It is evident that accurate phenotyping, which includes the measurement of biomarkers, is crucial in achieving clinical remission for each patient.
  • Abstract Link
  • Full Text Link

Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension

  • Annals of the American Thoracic Society
  • June 2024
  • The objective of this study is to characterize the pattern of right heart dysfunction (RHD) on electrocardiogram (ECG) in patients with pulmonary arterial hypertension (PAH) and to explore the correlation of this pattern with clinical indicators of disease severity and prognosis.
  • Abstract Link
  • Full Text Link

DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients

  • Chest
  • June 2024
  • What is the diagnostic accuracy of the main parameters utilized for pulmonary hypertension (PH) screening in identifying patients with systemic sclerosis (SSc) who have a mean pulmonary artery pressure (mPAP) of 21-24 mmHg during right heart catheterization (RHC)?
  • Full Text Link

A Real-World Assessment of Stage I Lung Cancer Through Electronic Nose Technology

  • Journal of Thoracic Oncology
  • May 2024
  • The use of Electronic Nose (E-nose) technology has shown promising sensitivity and specificity in the context of lung cancer screening. However, its effectiveness in detecting early-stage tumors is still uncertain. Therefore, our study aimed to evaluate the diagnostic accuracy of E-nose technology in identifying clinical stage I lung cancer.
  • Abstract Link
  • Full Text Link

Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance

  • American Journal of Respiratory and Critical Care Medicine
  • June 2024
  • This study aims to evaluate the mechanisms that contribute to the heightened dyspnea and decreased exercise capacity observed in individuals with PRISm. By examining these factors, we hope to gain a better understanding of the physiological processes at play in this population.
  • Abstract Link
  • Full Text Link

Lipids to the Rescue in Pulmonary Fibrosis: Biosynthesis, Bioenergetics or Epigenetics?

  • American Journal of Respiratory Cell and Molecular Biology
  • May 2024
  • There is a growing recognition of the significant role that lipid metabolism plays in the development of lung fibrosis. However, there is still uncertainty surrounding the precise molecular mechanisms involved in this process.
  • Abstract Link
  • Full Text Link

Radiotherapy improves survival in Non-small cell lung cancer following oligoprogression on immunotherapy: A cohort study

  • JTO Clinical and Research Reports
  • May 2024
  • The patterns of oligoprogression following first-line immune checkpoint inhibitors (ICIs) for metastatic non-small cell lung cancer (NSCLC) have not been well established. However, there is a growing body of evidence indicating that targeted radiotherapy may enhance survival rates in patients experiencing progression after receiving ICIs.
  • Full Text Link

Phage Therapy for Respiratory Infections: Opportunities and Challenges

  • Lung
  • May 2024
  • In this review, researchers examine the current status of phage therapy in the treatment of chronic respiratory diseases. They explore how phage therapy has the potential to overcome significant microbiological barriers that impede the resolution of chronic lung infections when compared to traditional antibiotic treatments. Additionally, discussing the challenges that need to be overcome in order to successfully conduct clinical trials for phage therapy.
  • Abstract Link
  • Full Text Link

Asthma control in the United States: relationships between short-acting β2-agonist and systemic corticosteroid use

  • Annals of Allergy, Asthma and Immunology
  • May 2024
  • In order to gauge the prevalence of uncontrolled asthma, the researchers examined the correlation between the frequency of prescriptions for systemic corticosteroids (SCS) and short-acting ß2-agonists (SABA) as indicators of risk and impairment, respectively.
  • Abstract Link
  • Full Text Link

There you have it – a look at some of the most popular pulmonology publications recently released. Sign up for alerts and stay informed on the latest published guidelines and articles.

Copyright © 2024 Guideline Central, All rights reserved.